Jan 6 (Reuters) - Valeant Pharmaceuticals International Inc (N:VRX) VRX.TO :
* Names howard b. schiller interim CEO
* Says robert ingram, lead independent director, to serve as interim chairman
* Says j. michael pearson to remain on medical leave of absence
* Schiller served as valeant's CFO from December 2011 through June 2015 and
currently serves on valeant's board of directors
* Says j. michael pearson remains in the hospital where he is being treated for
severe pneumonia
* Ingram has been serving on co's board since September 2010, and was the
chairman of the board from December 2010 to March 2011
* Timing of pearson's expected return "uncertain"
* Source text for Eikon ID:nCNWT0gDca
* Further company coverage VRX.TO